We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$30.2B
AUM Growth
+$429M
Cap. Flow
+$566M
Cap. Flow %
1.87%
Top 10 Hldgs %
43.77%
Holding
322
New
7
Increased
69
Reduced
120
Closed
12

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$25.9M
2
ABBV icon
AbbVie
ABBV
+$24.6M
3
CB icon
Chubb
CB
+$19M
4
MO icon
Altria Group
MO
+$4.04M
5
DIS icon
Walt Disney
DIS
+$3.89M

Sector Composition

Rank Sector Weight
1 Technology 23.12%
2 Financials 20.7%
3 Consumer Staples 17.45%
4 Communication Services 11.35%
5 Healthcare 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORCL icon
126
Oracle
ORCL
$409B
$4.09M 0.01%
46,897
HON icon
127
Honeywell
HON
$78.2B
$3.82M 0.01%
19,093
-4,103
-18% -$875K
CPT icon
128
Camden Property Trust
CPT
$11B
$3.76M 0.01%
25,470
+140
+0.6% +$20.5K
FOX icon
129
Fox Class B
FOX
$22.1B
$3.6M 0.01%
96,853
-66
-0.1% -$2.26K
CL icon
130
Colgate-Palmolive
CL
$71.6B
$3.44M 0.01%
45,444
-1,805
-4% -$143K
IBM icon
131
IBM
IBM
$213B
$3.4M 0.01%
25,629
-8,322
-25% -$1.11M
ITW icon
132
Illinois Tool Works
ITW
$83B
$3.17M 0.01%
15,343
AMGN icon
133
Amgen
AMGN
$204B
$3.12M 0.01%
14,668
-4,127
-22% -$950K
OKE icon
134
Oneok
OKE
$55.6B
$3.11M 0.01%
53,677
-1,100
-2% -$59.1K
RETA
135
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$3.03M 0.01%
30,129
NSC icon
136
Norfolk Southern
NSC
$75.6B
$3.02M 0.01%
12,609
-287
-2% -$73.6K
CDK
137
DELISTED
CDK Global, Inc.
CDK
$2.96M 0.01%
69,466
-3,216
-4% -$145K
SYY icon
138
Sysco
SYY
$40.7B
$2.85M 0.01%
36,321
-300
-0.8% -$22.9K
BIIB icon
139
Biogen
BIIB
$29.8B
$2.84M 0.01%
10,028
BTI icon
140
British American Tobacco
BTI
$128B
$2.73M 0.01%
77,250
OVV icon
141
Ovintiv
OVV
$17.1B
$2.69M 0.01%
81,733
SPY icon
142
State Street SPDR S&P 500 ETF Trust
SPY
$806B
$2.69M 0.01%
6,257
+3,918
+168% +$1.73M
CCI icon
143
Crown Castle
CCI
$33.5B
$2.59M 0.01%
14,938
-2,538
-15% -$491K
AVGO icon
144
Broadcom
AVGO
$1.87T
$2.52M 0.01%
52,060
-12,240
-19% -$595K
UL icon
145
Unilever
UL
$137B
$2.4M 0.01%
39,379
-89
-0.2% -$5.67K
RL icon
146
Ralph Lauren
RL
$22.6B
$2.32M 0.01%
20,900
EMR icon
147
Emerson Electric
EMR
$86.7B
$2.3M 0.01%
24,438
+2,779
+13% +$277K
EW icon
148
Edwards Lifesciences
EW
$51.1B
$2.26M 0.01%
19,976
PYPL icon
149
PayPal
PYPL
$49.5B
$2.26M 0.01%
8,687
UPS icon
150
United Parcel Service
UPS
$90.8B
$2.23M 0.01%
12,266
-1,573
-11% -$310K

Similar funds

Fayez Sarofim & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Fayez Sarofim & Co held 322 positions worth $30.2B, up 1.4% from $29.8B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Fayez Sarofim & Co's Q3 2021 filing shows 7 new, 69 increased, 120 reduced and 12 closed positions. Its largest new stake was Netflix: 23,560 shares worth $1.44M. The largest sale was Apple, an estimated $25.9M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Staples.

  • Fayez Sarofim & Co's largest Q3 2021 buy was Netflix: 23,560 shares worth $1.44M.
  • Fayez Sarofim & Co added most to Amazon in Q3 2021, an estimated $76.3M increase.
  • Fayez Sarofim & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $25.9M.
  • Fayez Sarofim & Co fully exited NVIDIA in Q3 2021, selling an estimated $1.06M.
  • Fayez Sarofim & Co's ten largest holdings make up 44% of its $30.2B portfolio in Q3 2021.
  • Fayez Sarofim & Co opened 7 new positions and closed 12 in Q3 2021.
  • Fayez Sarofim & Co's portfolio value rose 1.4% quarter-over-quarter to $30.2B.

Based on Fayez Sarofim & Co's 13F filing for Q3 2021, filed 15 Nov 2021.